Article
Ongoing equipoise contributes to unchanged outcomes and significant morbidity following post-transplant cutaneous squamous cell carcinoma: A Multicentre Cohort Study
2025-06-04
Abstract excerpt
<h4>Introduction</h4> Cutaneous squamous cell carcinoma (CSCC) is the most common post-transplant malignancy, ultimately affecting up to half of all recipients. Historical cohort studies indicate that up to 25% of recipients develop further post-transplant CSCC within 12 months of their first. Post-transplant CSCC incurs doubled risk of metastasis and death compared to the general population and there is uncertain...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0bc4e309-0fa1-5df7-9725-fea0edc14c54
- DOI
- 10.1101/2025.06.02.25328493
